• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酸半胱氨酸连接酶修饰亚基(GCLM)基因与日本人群中的甲基苯丙胺使用障碍或精神分裂症无关。

Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.

作者信息

Kishi Taro, Ikeda Masashi, Kitajima Tsuyoshi, Yamanouchi Yoshio, Kinoshita Yoko, Kawashima Kunihiro, Inada Toshiya, Harano Mutsuo, Komiyama Tokutaro, Hori Toru, Yamada Mitsuhiko, Iyo Masaomi, Sora Ichiro, Sekine Yoshimoto, Ozaki Norio, Ujike Hiroshi, Iwata Nakao

机构信息

Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.

出版信息

Ann N Y Acad Sci. 2008 Oct;1139:63-9. doi: 10.1196/annals.1432.022.

DOI:10.1196/annals.1432.022
PMID:18991850
Abstract

A recent study showed a significant association between schizophrenia in European samples and the glutamate cysteine ligase modifier (GCLM) subunit gene, which is the key glutathione (GSH)-synthesizing enzyme. Since the symptoms of methamphetamine (METH)-induced psychosis are similar to those of schizophrenia, the GCLM gene is thought to be a good candidate gene for METH-use disorder or related disorders. To evaluate the association between the GCLM gene and METH-use disorder and schizophrenia, we conducted a case-control study of Japanese subjects (METH-use disorder, 185 cases; schizophrenia, 742 cases; and controls, 819). Four SNPs (2 SNPs from an original report and JSNP database, and 2 "tagging SNPs" from HapMap database) in the GCLM gene were examined in this association analysis; one SNP showed an association with both METH-use disorder and METH-induced psychosis. After Bonferroni's correction for multiple testing, however, this significance disappeared. No significant association was found with schizophrenia. Our findings suggest that a common genetic variation in the GCLM gene might not contribute to the risk of METH-use disorder and schizophrenia in the Japanese population.

摘要

最近一项研究表明,在欧洲样本中,精神分裂症与谷氨酸半胱氨酸连接酶调节亚基(GCLM)基因之间存在显著关联,该基因是关键的谷胱甘肽(GSH)合成酶。由于甲基苯丙胺(METH)所致精神病的症状与精神分裂症相似,GCLM基因被认为是METH使用障碍或相关疾病的一个良好候选基因。为了评估GCLM基因与METH使用障碍及精神分裂症之间的关联,我们对日本受试者进行了一项病例对照研究(METH使用障碍,185例;精神分裂症,742例;对照,819例)。在该关联分析中检测了GCLM基因中的4个单核苷酸多态性(SNPs)(2个来自原始报告和JSNP数据库,2个来自HapMap数据库的“标签SNPs”);其中一个SNP显示与METH使用障碍和METH所致精神病均有关联。然而,在进行Bonferroni多重检验校正后,这种显著性消失了。未发现与精神分裂症有显著关联。我们的研究结果表明,GCLM基因中的常见基因变异可能对日本人群中METH使用障碍和精神分裂症的风险没有影响。

相似文献

1
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.谷氨酸半胱氨酸连接酶修饰亚基(GCLM)基因与日本人群中的甲基苯丙胺使用障碍或精神分裂症无关。
Ann N Y Acad Sci. 2008 Oct;1139:63-9. doi: 10.1196/annals.1432.022.
2
Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.5-羟色胺 1A 受体基因与日本甲基苯丙胺所致精神病患者相关。
Neuropharmacology. 2010 Feb;58(2):452-6. doi: 10.1016/j.neuropharm.2009.09.006. Epub 2009 Sep 10.
3
Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.NRG1 基因与日本人群甲基苯丙胺所致精神病的关联分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):903-5. doi: 10.1016/j.pnpbp.2009.04.016. Epub 2009 Apr 24.
4
Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.日本人群中钙调神经磷酸酶Aγ亚基基因(PPP3CC)与甲基苯丙胺使用障碍的关联研究。
Ann N Y Acad Sci. 2008 Oct;1139:57-62. doi: 10.1196/annals.1432.021.
5
Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population.神经元烟碱型乙酰胆碱受体基因的α4和β2亚基与日本人群中的甲基苯丙胺使用障碍无关。
Ann N Y Acad Sci. 2008 Oct;1139:70-82. doi: 10.1196/annals.1432.023.
6
Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.5-羟色胺 6 受体基因与日本人的甲基苯丙胺所致精神病有关。
Drug Alcohol Depend. 2011 Jan 1;113(1):1-7. doi: 10.1016/j.drugalcdep.2010.06.021. Epub 2010 Aug 11.
7
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.GRIA3 基因的遗传变异与甲基苯丙胺依赖及其相关精神病的易感性有关。
J Psychopharmacol. 2018 Mar;32(3):309-315. doi: 10.1177/0269881117750153. Epub 2018 Jan 17.
8
Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.精神分裂症患者谷氨酸半胱氨酸连接酶修饰亚基(GCLM)基因的突变筛查
Psychiatr Genet. 2009 Aug;19(4):201-8. doi: 10.1097/YPG.0b013e32832cef21.
9
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.甲基苯丙胺所致精神病与精神分裂症之间存在共享遗传风险的证据。
Neuropsychopharmacology. 2013 Sep;38(10):1864-70. doi: 10.1038/npp.2013.94. Epub 2013 Apr 12.
10
Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.GRM2 和 HTR2A 与日本人群中甲基苯丙胺所致精神病和精神分裂症的关联分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):639-44. doi: 10.1016/j.pnpbp.2010.03.002. Epub 2010 Mar 6.

引用本文的文献

1
Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.冰毒使用障碍的遗传学:基因关联研究的系统综述和荟萃分析。
Neurosci Biobehav Rev. 2021 Jan;120:48-74. doi: 10.1016/j.neubiorev.2020.11.001. Epub 2020 Nov 17.
2
Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.对与精神分裂症风险相关的10种多态性的荟萃分析。
Biomed Rep. 2014 Sep;2(5):729-736. doi: 10.3892/br.2014.308. Epub 2014 Jun 30.
3
Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence.
促动力素 2 基因与日本甲基苯丙胺依赖之间缺乏关联。
Curr Neuropharmacol. 2011 Mar;9(1):133-6. doi: 10.2174/157015911795016994.
4
Genetic association studies of antioxidant pathway genes and schizophrenia.抗氧化途径基因与精神分裂症的遗传关联研究。
Antioxid Redox Signal. 2011 Oct 1;15(7):2037-45. doi: 10.1089/ars.2010.3508. Epub 2010 Nov 1.